Meyka AI API is live for developers.Start building.
Advertisement
Rent-A-Center, Inc.

RCII News Today: Stay Updated with the Latest Rent-A-Center, Inc. News in Real Time

Find RCII news now at Meyka AI. Stay informed with the latest{" "} Rent-A-Center, Inc. stocks updates, including price news, market analysis, and expert insights.

RCIINASDAQ
IndustrialsRental & Leasing Services
$26.78
$0.03(0.11%)
U.S. Market opens in 59h 10m
Advertisement
8th Pay Commission Deadline Extended to June 15 as Pension Demands Rise
📅 1 hour ago

8th Pay Commission Deadline Extended to June 15 as Pension Demands Rise

8th Pay Commission deadline extended to June 15. Central government employees await salary revision, pension hikes, and arrears up to ₹1.87 lakh.

Read more 12
MSTR Stock Crashes 13% as Bitcoin Sale Breaks “Never Sell” Promise, June 05
📅 5 hours ago

MSTR Stock Crashes 13% as Bitcoin Sale Breaks “Never Sell” Promise, June 05

MSTR stock falls 13% after Strategy Inc sells 32 Bitcoin for first time in years, breaking its “never sell” pledge.

Read more 12
META Stock Momentum Builds: Meta Platforms Inc Gains 0.74% to $627.57 as Roundview Capital LLC Raises Holdings
📅 8 hours ago

META Stock Momentum Builds: Meta Platforms Inc Gains 0.74% to $627.57 as Roundview Capital LLC Raises Holdings

META stock gained 0.74% to close at $627.57, signaling renewed investor confidence in Meta Platforms Inc as institutional investors continue to increase their positions. The upward move comes at a time when technology stocks are regaining momentum, supported by strong earnings expectations and continued growth in artificial intelligence investments. The latest filing shows that Roundview…

Read more 12
Japan Backs Rapidus With $943M as 2nm Chip Push Accelerates, June 05
📅 9 hours ago

Japan Backs Rapidus With $943M as 2nm Chip Push Accelerates, June 05

Japan invests $943M in Rapidus for 2-nanometer chip production by 2027, bringing total government backing to $1.8B for semiconductor sovereignty.

Read more 12
Lululemon Stock Target Cut by UBS as EPS Guidance Falls to $10.95–$11.15 
📅 9 hours ago

Lululemon Stock Target Cut by UBS as EPS Guidance Falls to $10.95–$11.15 

Lululemon Stock is under strong pressure after a fresh wave of analyst revisions and weak forward guidance. UBS has cut its price target following a sharp downward revision in earnings expectations. The biggest concern for investors is simple. The company now expects full-year EPS between $10.95 and $11.15, down from earlier forecasts that were significantly…

Read more 12
Andrew Mountbatten-Windsor Sublet Cottages on Rent-Free Estate, June 05
📅 9 hours ago

Andrew Mountbatten-Windsor Sublet Cottages on Rent-Free Estate, June 05

NAO report shows Andrew Mountbatten-Windsor sublet Royal Lodge cottages for 20 years while paying peppercorn rent. King funds non-working…

Read more 12
FUBO Stock Falls 6.2% to $10.06 as Earnings Loom, June 04
📅 1 day ago

FUBO Stock Falls 6.2% to $10.06 as Earnings Loom, June 04

FUBO stock fell 6.2% to $10.06 on June 04. Meyka rates it a C with a sell recommendation and $5.94 price target.

Read more 12
Trump Administration Appeals $166B Tariff Refund Order, June 04
📅 1 day ago

Trump Administration Appeals $166B Tariff Refund Order, June 04

Trump administration appeals court order to refund $166 billion in illegal tariffs. CBP has processed $35.5 billion in refunds to date.

Read more 12
UnitedHealth Group Inc (UNH) at $377.00: Flat 0.24% as Q1 2026 Revenue Hits $111.72B (+1.96% YoY)
📅 1 day ago

UnitedHealth Group Inc (UNH) at $377.00: Flat 0.24% as Q1 2026 Revenue Hits $111.72B (+1.96% YoY)

UnitedHealth Group Inc remained on investors’ watchlists after the healthcare giant reported first-quarter 2026 results that showed steady growth despite a challenging healthcare environment. The stock traded at $377.00, up 0.24%, while quarterly revenue reached $111.72 billion, reflecting 1.96% year-over-year growth. The earnings report highlighted strength across the company’s insurance and healthcare services businesses, helping…

Read more 12

RCII News FAQ